Location: United Kingdom & United States
The Magseed marker is a tiny device that can be implanted by radiology any time before the patent’s operation for breast cancer. It offers more flexibility, accuracy, and improves comfort over the traditional guidewire.
In the US, 1 in 8 women will develop breast cancer in their lifetime, making it the second most common cancer in women after skin cancer. When it is time for the patient to undergo surgery, they typically head to the radiology department. Here, they have guidewires placed to mark the site of cancer. With the wires in place, they then transfer to a different part of the hospital, sometimes another building, where the surgery will take place.
The process is highly uncomfortable and can add to the anxiety the woman is already feeling about her operation. Endomag, a medtech company working to improve the standard of care for cancer patients, has developed a less invasive alternative.
The Endomag Magseed marker is a tiny seed-sized device that is implanted to mark the cancer site with greater accuracy. It’s only 5mm in size. Unlike the traditional method with wires, the Magseed can be implanted well before the surgery, which helps reduce the stress the patient may be feeling. It cannot be dislodged and offers more precision to aid in the likelihood for a positive outcome post-surgery – The chance of needing further surgery is 6.5% compared to up to 25% if using a guidewire.